Irritable Bowel Syndrome News and Research

Latest Irritable Bowel Syndrome News and Research

Primary headache patients diagnosed with more comorbidities have high healthcare costs, research shows

Research presented at the Academy of Managed Care Pharmacy (AMCP) Nexus in early October in Washington, DC, showed that 60 percent of adult patients who were diagnosed with primary headache had one or more comorbidities which raised the average annual cost of their healthcare to over $20,000.

24 Oct 2016

New report underscores personal and economic impact of IBS

A multi-disciplinary expert group calls for greater attention to be paid to Irritable Bowel Syndrome (IBS) to bring it out of the shadows. The IBS Global Impact Report is launched at United European Gastroenterology Week and examines published studies on the direct and indirect costs of IBS.

19 Oct 2016

Common drug for allergies and asthma could prevent fibrosis, reduce need for liver transplants

A drug commonly used for the prevention of allergies and asthma someday could find new use in preventing liver disease and reducing the need for transplants, according to new research published in the October 2016 edition of the scientific journal Hepatology.

12 Oct 2016

Alternative therapies appear to be effective in ameliorating IBS symptoms

A new review looks at the evidence behind the effectiveness of complementary or alternative therapies-including probiotics, prebiotics, synbiotics, fiber, and herbal medicinal products-for the treatment of bowel disorders such as irritable bowel syndrome (IBS), functional constipation, and ulcerative colitis.

3 Oct 2016

Harvard symposium highlights health impact of gut microbiota and probiotics throughout lifespan

Danone Nutricia Research, one of the key sponsors of the September 15th and 16th Harvard Medical School Division of Nutrition symposium on gut microbiota, probiotics and their impact throughout the lifespan, announces its continued support of research in the emerging field of the microbiome and its interactions with body functions.

30 Sep 2016

New partnership between BetterYou and University of Sheffield paves way for vitamin D research

A new collaboration between health pioneers BetterYou and scientists from the University of Sheffield, is paving the way for a three-year clinical trial looking at the effect of vitamin D supplementation on the quality of life of people with Irritable Bowel Syndrome (IBS).

From BetterYou Ltd 21 Sep 2016

Food intolerance testing: an interview with Dr Gill Hart

Food intolerances are caused by adverse reactions to food or drink ingredients in your body. These are very different to food allergies. It is estimated that up to forty-five percent of the population suffers from food intolerances.

15 Sep 2016

Study demonstrates significant reduction in severity of exercise-induced asthma following B-GOS consumption

Clasado Biosciences Limited, the producers and suppliers of Bimuno(R) (B-GOS), a unique patented trans-galactooligosaccharide complex, today announces the publication of results for the latest clinical study using B-GOS.

5 Aug 2016

New research shows independent gut-to-brain and brain-to-gut pathways operate in IBS patients

New research indicates that in patients with irritable bowedistinct brain-to-gut pathway, where psychological symptoms begin first, and separately a distinctl syndrome (IBS) or indigestion, there is a gut-to-brain pathway, where gut symptoms start first.

22 Jul 2016

Low-FODMAP rye bread may reduce symptoms of IBS

Patients with irritable bowel syndrome (IBS) are often concerned that certain foods may trigger or worsen their symptoms, which can include abdominal pain, diarrhea, or constipation. In a new study, patients who ate rye bread that was low in so-called "FODMAPs" (fermentable oligo- di- and mono-saccharides and polyols) experienced milder IBS symptoms than patients who ate normal rye bread.

18 Jul 2016

Treatment for IBS proves difficult, survey reveals

A new national survey by Health Union of more than 1,000 individuals with Irritable Bowel Syndrome (IBS) reveals that the condition is difficult to diagnose and often even more difficult to treat.

29 Jun 2016

Scientists find link between makeup of individual's microbiome and head and neck cancer

In a sample study, researchers at Johns Hopkins say they have found an association between the makeup of an individual's microbiome and head and neck cancer, a finding that potentially advances the quest for faster and more accurate cancer diagnosis and therapy.

28 Jun 2016

Researchers play crucial role in crafting diagnostic criteria for functional GI disorders

With no laboratory test available to diagnose functional gastrointestinal disorders, proper diagnostic criteria are critical for clinicians to make an accurate determination of what ails their patients.

22 Jun 2016

Tarantula venom could help provide relief for patients suffering from Irritable Bowel Syndrome

Researchers from The University of Adelaide in South Australia found that a specific peptide in the spider venom could be used to understand how people sense pain.

7 Jun 2016

Spider venom helps investigate pain signals experienced by irritable bowel syndrome patients

Spiders have helped researchers from Australia and the US discover a new target for irritable bowel syndrome pain.

7 Jun 2016

Rome IV criteria helps diagnose, treat gastrointestinal conditions in children

A child feels nauseated all the time, but no medical test can find what is wrong. Or a child vomits regularly, but there's no illness or eating disorder to explain it. These, and other stomach and bowel-related problems with no obvious causes, are called functional gastrointestinal disorders.

1 Jun 2016

Diet-based therapy may improve quality of life in IBS patients

A change in diet can improve the lives of those diagnosed with a common, but hard-to-treat gut disorder.

25 May 2016

Gut-directed hypnosis more effective for treating irritable bowel syndrome

Therapeutic hypnosis is an effective and safe complementary technique in surgery and the treatment of irritable bowel syndrome. This is the conclusion of a systematic review by Winfried Häuser and his co-authors in the latest issue of Deutsches Ärzteblatt International.

23 May 2016

Set of 16 different substances in the breath can help identify IBS patients

There is currently no specific diagnostic test for irritable bowel syndrome (IBS), but now researchers have identified a combination of 16 different substances in the breath that, when measured together, can accurately distinguish IBS patients from people without the condition.

11 May 2016

RedHill Biopharma initiates phase II study of BEKINDA for irritable bowel syndrome

RedHill Biopharma Ltd. (NASDAQ; RDHL) (TASE: RDHL) (“RedHill” or the “Company”), a biopharmaceutical company primarily focused on development and commercialization of late clinical-stage, proprietary, orally-administered, small molecule drugs for inflammatory and gastrointestinal diseases, including cancer, today announced that it has initiated a randomized, double-blind, 2-arm parallel group Phase II clinical study in the U.S. evaluating the safety and efficacy of BEKINDA™ 12 mg in patients with diarrhea-predominant irritable bowel syndrome (IBS-D).

13 Apr 2016

Irritable Bowel Syndrome News and Research

Latest Irritable Bowel Syndrome News and Research

Primary headache patients diagnosed with more comorbidities have high healthcare costs, research shows

New report underscores personal and economic impact of IBS

Common drug for allergies and asthma could prevent fibrosis, reduce need for liver transplants

Alternative therapies appear to be effective in ameliorating IBS symptoms

Harvard symposium highlights health impact of gut microbiota and probiotics throughout lifespan

New partnership between BetterYou and University of Sheffield paves way for vitamin D research

Food intolerance testing: an interview with Dr Gill Hart

Study demonstrates significant reduction in severity of exercise-induced asthma following B-GOS consumption

New research shows independent gut-to-brain and brain-to-gut pathways operate in IBS patients

Low-FODMAP rye bread may reduce symptoms of IBS

Treatment for IBS proves difficult, survey reveals

Scientists find link between makeup of individual's microbiome and head and neck cancer

Researchers play crucial role in crafting diagnostic criteria for functional GI disorders

Tarantula venom could help provide relief for patients suffering from Irritable Bowel Syndrome

Spider venom helps investigate pain signals experienced by irritable bowel syndrome patients

Rome IV criteria helps diagnose, treat gastrointestinal conditions in children

Diet-based therapy may improve quality of life in IBS patients

Gut-directed hypnosis more effective for treating irritable bowel syndrome

Set of 16 different substances in the breath can help identify IBS patients

RedHill Biopharma initiates phase II study of BEKINDA for irritable bowel syndrome

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Irritable Bowel Syndrome News and Research

Latest Irritable Bowel Syndrome News and Research

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Newsletters you may be interested in